Medallion Wealth Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.5K Hold
750
0.01% 603
2026
Q1
$26.5K Hold
750
0.01% 597
2025
Q4
$30.4K Hold
750
0.01% 566
2025
Q3
$35.3K Hold
750
0.01% 529
2025
Q2
$40.6K Buy
+750
New +$41.2K 0.02% 493

Other funds holding CNMD

Medallion Wealth Advisors's CNMD Position: Q2 2026 in Review

Medallion Wealth Advisors held its CONMED (CNMD) position steady in Q2 2026 at 750 shares worth $24.5K. The position accounts for 0.01% of the portfolio, ranked #603.

Medallion Wealth Advisors first reported a position in CNMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $40.6K in Q2 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Medallion Wealth Advisors held 750 shares of CONMED worth $24.5K as of Q2 2026.
  • Medallion Wealth Advisors left its CONMED share count unchanged in Q2 2026.
  • CONMED made up 0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #603 holding.
  • Medallion Wealth Advisors first reported a position in CONMED in Q2 2025 and has held it in 5 quarters since.
  • Medallion Wealth Advisors's CONMED position peaked at $40.6K in Q2 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.